BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34290537)

  • 1. Leukapheresis Does Not Improve Early Survival Outcome of Acute Myeloid Leukemia with Leukostasis Patients - A Dual-Center Retrospective Cohort Study.
    Rinaldi I; Sari RM; Tedhy VU; Winston K
    J Blood Med; 2021; 12():623-633. PubMed ID: 34290537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
    Choi MH; Choe YH; Park Y; Nah H; Kim S; Jeong SH; Kim HO
    Transfusion; 2018 Jan; 58(1):208-216. PubMed ID: 28960357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose cyclophosphamide for cytoreduction in patients with acute myeloid leukemia with hyperleukocytosis or leukostasis.
    Zhao J; Bewersdorf JP; Jaszczur S; Kowalski A; Perreault S; Schiffer M; Gore S; Podoltsev N; Prebet T; Shallis R; Zeidan AM
    Leuk Lymphoma; 2021 May; 62(5):1195-1202. PubMed ID: 33325761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits.
    Shallis RM; Stahl M; Bewersdorf JP; Hendrickson JE; Zeidan AM
    Expert Rev Hematol; 2020 May; 13(5):489-499. PubMed ID: 32248712
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study.
    Stahl M; Shallis RM; Wei W; Montesinos P; Lengline E; Neukirchen J; Bhatt VR; Sekeres MA; Fathi AT; Konig H; Luger S; Khan I; Roboz GJ; Cluzeau T; Martínez-Cuadron D; Raffoux E; Germing U; Umakanthan JM; Mukherjee S; Brunner AM; Miller A; McMahon CM; Ritchie EK; Rodríguez-Veiga R; Itzykson R; Boluda B; Rabian F; Tormo M; Acuña-Cruz E; Rabinovich E; Yoo B; Cano I; Podoltsev NA; Bewersdorf JP; Gore S; Zeidan AM
    Leukemia; 2020 Dec; 34(12):3149-3160. PubMed ID: 32132655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.
    Bug G; Anargyrou K; Tonn T; Bialleck H; Seifried E; Hoelzer D; Ottmann OG
    Transfusion; 2007 Oct; 47(10):1843-50. PubMed ID: 17880610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
    Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
    Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prophylactic leukapheresis on early mortality and overall survival in acute leukemia patients with hyperleukocytosis.
    Göçer M; Kurtoğlu E
    Ther Apher Dial; 2021 Oct; 25(5):697-703. PubMed ID: 33686785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center.
    Nan X; Qin Q; Gentille C; Ensor J; Leveque C; Pingali SR; Phan AT; Rice L; Iyer S
    Leuk Lymphoma; 2017 Sep; 58(9):1-11. PubMed ID: 28140714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of therapeutic leukapheresis in hyperleukocytotic AML.
    Pastore F; Pastore A; Wittmann G; Hiddemann W; Spiekermann K
    PLoS One; 2014; 9(4):e95062. PubMed ID: 24733550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic leukapheresis in patients with leukostasis secondary to acute myelogenous leukemia.
    De Santis GC; de Oliveira LC; Romano LG; Almeida Prado Bde P; Simoes BP; Rego EM; Covas DT; Falcao RP
    J Clin Apher; 2011; 26(4):181-5. PubMed ID: 21574176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exchange Transfusion and Leukapheresis in Pediatric Patients with AML With High Risk of Early Death by Bleeding and Leukostasis.
    Creutzig U; Rössig C; Dworzak M; Stary J; von Stackelberg A; Wössmann W; Zimmermann M; Reinhardt D
    Pediatr Blood Cancer; 2016 Apr; 63(4):640-5. PubMed ID: 26670831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of hyperleukocytosis in 2017: Do we still need leukapheresis?
    Korkmaz S
    Transfus Apher Sci; 2018 Feb; 57(1):4-7. PubMed ID: 29477941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic mutations and leukapheresis in acute myeloid leukemia: is there a link?
    Corbingi A; Putzulu R; Massini G; Colangelo M; Minnella G; Chiusolo P; Sica S; Piccirillo N
    Ann Hematol; 2023 Oct; 102(10):2735-2740. PubMed ID: 37592090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic Patients with Hyperleukocytic FLT3-ITD Mutated Acute Myeloid Leukemia Might Benefit from Leukapheresis.
    Farid KMN; Sauer T; Schmitt M; Müller-Tidow C; Schmitt A
    Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful induction therapy for acute myeloid leukemia complicated with brain hemorrhage and hyperleukocytosis].
    Miyazaki T; Abe N; Yamazaki E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Tachibana T; Kamijo A; Tomita N; Ishigastubo Y
    Rinsho Ketsueki; 2016 Feb; 57(2):180-5. PubMed ID: 26935637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?
    Bewersdorf JP; Zeidan AM
    Cells; 2020 Oct; 9(10):. PubMed ID: 33080779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperleukocytosis, leukostasis and leukapheresis: practice management.
    Ganzel C; Becker J; Mintz PD; Lazarus HM; Rowe JM
    Blood Rev; 2012 May; 26(3):117-22. PubMed ID: 22364832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukapheresis in patients newly diagnosed with acute myeloid leukemia.
    Villgran V; Agha M; Raptis A; Hou JZ; Farah R; Lim SH; Redner RL; Im A; Sehgal A; Dorritie KA; Kiss JE; Normolle D; Boyiadzis M
    Transfus Apher Sci; 2016 Oct; 55(2):216-220. PubMed ID: 27470709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukapheresis do not improve early death rates in acute myeloid leukemia patients with hyperleukocytosis.
    Malkan UY; Ozcebe OI
    Transfus Apher Sci; 2017 Dec; 56(6):880-882. PubMed ID: 29153308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.